Ginkgo Bioworks Inc.
DNA | NYSE
$7.98
+$0.10 (+1.27%)
At close: Sep 21, 2026, 4:00 PM ET
$7.86
-$0.12 (-1.55%)
Pre-market:
Sep 22, 2026, 4:52 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 20.16M | 19.47M | 33.4M | 38.84M | 49.6M | 48.32M | 43.85M | 89.05M | 56.21M | 37.94M | 34.76M | 55.43M | 80.57M | 80.7M | 98.29M | 66.4M | 144.62M | 168.41M | 148.49M | 77.61M | 43.64M | 44.1M |
Cost of Revenue | 1.72M | 15.9M | -8.15M | 12.8M | 14.82M | 12.05M | 9.62M | 9.99M | 13.72M | 9.2M | 6.61M | 6.92M | 18.1M | 22.38M | 30.22M | 24.66M | 63.91M | 85.43M | 66.58M | 22.3M | 17.11M | 23.7M |
Gross Profit | 18.44M | 3.58M | 41.55M | 26.04M | 34.78M | 36.27M | 34.23M | 79.06M | 42.49M | 28.74M | 28.14M | 48.51M | 62.47M | 58.33M | 68.07M | 41.74M | 80.71M | 82.97M | 81.92M | 55.31M | 26.53M | 20.4M |
Operating Income | -58.55M | -71.37M | -70.75M | -90.02M | -65.54M | -88.97M | -103.61M | -55.2M | -222.95M | -178M | -178.12M | -286.39M | -184.15M | -215.75M | -234.51M | -654.94M | -647.78M | -675.37M | -1.68B | -26.67M | -59.95M | -57.12M |
Interest Income | 3.23M | 3.6M | 40.86M | 5.74M | 6.08M | 6.08M | 7.34M | 9.25M | 10.31M | 11.71M | 13.3M | 15.02M | 14.35M | 14.55M | 11.41M | 6.38M | 2.26M | n/a | 496K | 121K | n/a | n/a |
Pretax Income | -57.19M | -76.14M | -81.39M | -80.75M | -60.58M | -90.87M | -107.86M | -56.78M | -216.99M | -165.88M | -211.89M | -302.91M | -173.25M | -204.89M | -188.92M | -670.16M | -670.62M | -592.78M | -1.61B | -102.61M | -54.9M | -74.94M |
Net Income | -46.71M | -82.59M | -80.75M | -80.76M | -60.3M | -90.96M | -107.53M | -56.4M | -217.18M | -165.91M | -211.69M | -302.89M | -173.32M | -204.97M | -176.54M | -670.13M | -668.83M | -590.51M | -1.6B | -101.88M | -53.94M | -73.57M |
Selling & General & Admin | 30.78M | 37.83M | 46.01M | 44.95M | 43.28M | 49.04M | 57.3M | 52.29M | 66.29M | 70.29M | 89.22M | 82.03M | 102.34M | 111.43M | 121.42M | 435.22M | 438.43M | 434.77M | 781.63M | 28.96M | 34.44M | 17.93M |
Research & Development | 46.21M | 49.92M | 50.13M | 69.35M | 53.37M | 70.92M | 76.38M | 77.01M | 134.22M | 136.46M | 117.04M | 156.66M | 144.28M | 162.64M | 181.16M | 261.46M | 290.06M | 323.58M | 985.03M | 53.02M | 52.03M | 59.59M |
Other Expenses | n/a | -12.8M | 16.16M | 1.75M | 3.67M | 5.27M | 4.16M | 4.97M | 64.92M | n/a | n/a | 96.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 76.99M | 74.95M | 112.3M | 116.05M | 100.32M | 125.24M | 137.83M | 134.26M | 265.43M | 206.74M | 206.26M | 334.9M | 246.62M | 274.07M | 302.58M | 696.68M | 728.49M | 758.34M | 1.77B | 81.98M | 86.47M | 77.51M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 94K | n/a | n/a | n/a | 93K | n/a | n/a | n/a | n/a | n/a | n/a | 397K | 551K | 649K | 478K | 475K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 78.7M | 90.85M | 104.15M | 128.85M | 115.15M | 137.29M | 147.45M | 144.25M | 279.15M | 215.95M | 212.87M | 341.82M | 264.72M | 296.45M | 332.79M | 721.34M | 792.4M | 843.78M | 1.83B | 104.28M | 103.58M | 101.21M |
Income Tax Expense | 128K | -80K | -643K | 1K | -283K | 88K | -325K | -375K | 190K | 31K | -198K | -22K | 67K | 82K | -14.77M | -28K | -45K | -184K | -683K | -207K | -431K | -159K |
Shares Outstanding (Basic) | 62.09M | 59.56M | 55.46M | 55.63M | 54.86M | 54.24M | 51.89M | 52.24M | 51.33M | 49.93M | 49.11M | 48.77M | 48.14M | 47.77M | 45.6M | 40.77M | 40.52M | 39.9M | 36.94M | 33.09M | 32.31M | 32.26M |
Shares Outstanding (Diluted) | 62.09M | 59.56M | 55.46M | 55.63M | 54.86M | 54.24M | 51.89M | 52.25M | 51.38M | 49.99M | 49.47M | 48.77M | 48.34M | 47.92M | 46.42M | 40.77M | 40.52M | 40.19M | 38.29M | 33.09M | 32.31M | 32.26M |
EPS (Basic) | -0.75 | -1.39 | -1.43 | -1.45 | -1.10 | -1.68 | -2.07 | -1.08 | -4.23 | -3.32 | -4.28 | -6.21 | -3.59 | -4.28 | -3.78 | -16.44 | -16.51 | -14.69 | -41.82 | -3.08 | -1.67 | -2.28 |
EPS (Diluted) | -0.75 | -1.39 | -1.43 | -1.45 | -1.10 | -1.68 | -2.07 | -1.08 | -4.23 | -3.32 | -4.31 | -6.21 | -3.60 | -4.29 | -3.85 | -16.44 | -16.51 | -14.80 | -43.34 | -3.08 | -1.67 | -2.28 |
EBITDA | -44.36M | -63.34M | -34.87M | -66.59M | -46.07M | -68.33M | -143.48M | -35.09M | -140.69M | -153.01M | -288.88M | -169.12M | -155.6M | -185.93M | -131.03M | -662.25M | -660.58M | -583.44M | -1.6B | -93.68M | -47.25M | -68.83M |
EBIT | -56.67M | -76.14M | -81.39M | -80.75M | -61.87M | -83.7M | -159.14M | -52.26M | -158.02M | -165.88M | -302.77M | -190.18M | -173.25M | -204.89M | -146.85M | -670.16M | -670.62M | -592.38M | -1.61B | -101.96M | -54.42M | -74.46M |
Depreciation & Amortization | 12.32M | 12.8M | 46.53M | 14.17M | 15.79M | 15.37M | 15.65M | 17.17M | 17.33M | 12.87M | 13.88M | 21.06M | 17.65M | 18.96M | 15.82M | 7.91M | 10.03M | 8.94M | 8M | 8.28M | 7.17M | 5.63M |
Add to Watchlist
Select watchlists to add or remove DNA